Evidence map›Paper›PMID 22483737›Full record

GuidelineInternational journal of radiation oncology, biology, physics2012

Radiation Therapy Oncology Group consensus panel guidelines for the delineation of the clinical target volume in the postoperative treatment of pancreatic head cancer.

Karyn A Goodman, William F Regine, Laura A Dawson, Edgar Ben-Josef, Karin Haustermans, Walter R Bosch, Julius Turian, Ross A Abrams

Registry-linked trialOpen access · greenAbstract readClinical Trial, Phase IIIPractice GuidelineRandomized Controlled Trial
In one paragraph

Guideline in International journal of radiation oncology, biology, physics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04737551 (Adjuvant Chemoradiation Following Radical Resection of Pancreatic Ductal Adenocarcinoma, a Prospective Cohort Study), which is not on this map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04737551 unknown statusnot on this mapstarted 2020, after this paper: background citation

Adjuvant Chemoradiation Following Radical Resection of Pancreatic Ductal Adenocarcinoma, a Prospective Cohort Study

Typeobservational_patient_registrySponsorShanghai Zhongshan HospitalRan2020 to 2023Enrolled400ConditionsResectable Pancreatic Cancer, Adjuvant Chemoradiotherapy, SurgeryArmsFollow-up only, Adjuvant chemotherapy, Adjuvant chemoradiotherapy, Adjuvant chemoradiotherapy + Adjuvant chemotherapy
3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 135 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Article
  9. Role of Radiation Therapy for Biliary Tract Cancers.Current oncology (Toronto, Ont.) · 2025
    Review
  10. Review
  11. Article
  12. Analysis of Radiation Therapy Quality Assurance in NRG Oncology RTOG 0848.International journal of radiation oncology, biology, physics · 2024
    Article
  13. Article
  14. Article
  15. Review
  16. Adjuvant Chemoradiotherapy in Resected Pancreatic Ductal Adenocarcinoma: Where Does the Benefit Lie? A Nomogram for Risk Stratification and Patient Selection.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2022
    Article
  17. Recurrence patterns of pancreatic cancer treated with adjuvant intensity modulated radiotherapy.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2022
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 3 countries.

Karyn A GoodmanMemorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. goodmank@mskcc.org
William F Regine
Laura A Dawson
Edgar Ben-Josef
Karin Haustermans
Walter R Bosch
Julius Turian
Ross A Abrams
Rush University Medical Center · USKU Leuven · BEMemorial Sloan Kettering Cancer Center · USPrincess Margaret Cancer Centre · CAUniversity of Maryland, Baltimore · USUniversity of Michigan–Ann Arbor · US

Funding

ADVANCED TECHNOLOGY QA CENTERU24CA081647 · NCI · WASHINGTON UNIVERSITY · PI MICHALSKI, JEFF M. · 1999 to 2013
$22.8M
NCI NIH HHS U24 CA081647
6 · The paper itself

Abstract

purposeTo develop contouring guidelines to be used in the Radiation Therapy Oncology Group protocol 0848, a Phase III randomized trial evaluating the benefit of adjuvant chemoradiation in patients with resected head of pancreas cancer. METHODS AND MATERIALS: A consensus committee of six radiation oncologists with expertise in gastrointestinal radiotherapy developed stepwise contouring guidelines and an atlas for the delineation of the clinical target volume (CTV) in the postoperative treatment of pancreas cancer, based on identifiable regions of interest and margin expansions. Areas at risk for subclinical disease to be included in the CTV were defined, including nodal regions, anastomoses, and the preoperative primary tumor location. Regions of interest that could be reproducibly contoured on postoperative imaging after a pancreaticoduodenectomy were identified. Standardized expansion margins to encompass areas at risk were developed after multiple iterations to determine the optimal margin expansions.

resultsNew contouring recommendations based on CT anatomy were established. Written guidelines for the delineation of the postoperative CTV and normal tissues, as well as a Web-based atlas, were developed.

conclusionsThe postoperative abdomen has been a difficult area for effective radiotherapy. These new guidelines will help physicians create fields that better encompass areas at risk and minimize dose to normal tissues.

Indexed as

Medical IllustrationAnatomic LandmarksAortographyCeliac ArteryConsensusHumansMesenteric Artery, SuperiorOrgans at RiskPancreatic NeoplasmsPancreaticojejunostomyPortal VeinRadiation OncologyRadiography, AbdominalRadiotherapy Planning, Computer-AssistedTomography, X-Ray ComputedTumor Burden

Identifiers

PMID22483737
PMCPMC6211792
OpenAlexW2079124681

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.